NCT00295347View on ClinicalTrials.gov

Mineralocorticoid Receptor in the Treatment of Severe Depression

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Major Depression
Interventions
DRUG

Spironolactone

DRUG

fludrocortisone

DRUG

escitalopram

Trial Locations (1)

20246

University Hospital Hamburg-Eppendorf, Hamburg

All Listed Sponsors
lead

Universitätsklinikum Hamburg-Eppendorf

OTHER

NCT00295347 - Mineralocorticoid Receptor in the Treatment of Severe Depression | Biotech Hunter | Biotech Hunter